Hamilelikte 2-methyl-3-buten-2-ol kullanmaktan kaçınmalı mıyım? | VeriMom
No EU harmonised (Annex VI) reproductive classification was found for 2‑methyl‑3‑buten‑2‑ol (CAS 115‑18‑4) and authoritative safety reviews (RIFM peer‑reviewed assessment) identify a NOAEL of 50 mg/kg/day from repeat/developmental/reproductive studies and conclude current use is supported; supplier SDS entries that list H361 appear to be company self‑classifications, which per your rules do not by themselves raise h. Physicochemical data (log Kow ≈1.1, high water solubility) and RIFM exposure assessment support low but measurable systemic exposure from topical use, so exposure (e) is scored 1 for pregnancy (adult topical exposure).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- 2-methyl-3-buten-2-ol hamilelikte güvenli mi?
- No EU harmonised (Annex VI) reproductive classification was found for 2‑methyl‑3‑buten‑2‑ol (CAS 115‑18‑4) and authoritative safety reviews (RIFM peer‑reviewed assessment) identify a NOAEL of 50 mg/kg/day from repeat/developmental/reproductive studies and conclude current use is supported; supplier SDS entries that list H361 appear to be company self‑classifications, which per your rules do not by themselves raise h. Physicochemical data (log Kow ≈1.1, high water solubility) and RIFM exposure assessment support low but measurable systemic exposure from topical use, so exposure (e) is scored 1 for pregnancy (adult topical exposure).
- 2-methyl-3-buten-2-ol emzirirken güvenli mi?
- No evidence found of a specific lactation/transfer hazard or a harmonised reproductive hazard. Given low‑to‑moderate systemic absorption predicted from dermal exposure (RIFM assessment), maternal systemic exposure is expected to be low but measurable; therefore exposure for breastfeeding is scored 1. No mechanistic or human lactation data were identified.
- 2-methyl-3-buten-2-ol bebek cildi için güvenli mi?
- No infant‑specific reproductive or developmental hazard data were found and authoritative reviews do not flag the substance as a reproductive teratogen. Because infant skin has higher surface‑area‑to‑weight and an immature barrier, the exposure score is increased by +1 versus adult (adult e=1 → baby e=2) reflecting higher potential dermal absorption on 0–3 yr skin, though no infant‑specific absorption studies were identified.
- VeriMom 2-methyl-3-buten-2-ol nasıl puanlıyor?
- VeriMom 2-methyl-3-buten-2-ol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 33/100 (yüksek risk) olarak puanlar.
- Hamilelikte 2-methyl-3-buten-2-ol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.